Clinical Value of Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Levels in Term Neonates with Infection or Sepsis: A Prospective Study

Figure 4

Repeated measurements of plasma suPAR levels during the course of infection. The bars represent mean (95% confidence interval for mean) of suPAR concentrations. (a) Decline in suPAR levels in the entire population of infected neonates (𝑃<0.001) and comparison with levels in controls at sequential time points. (b) Decline in suPAR levels separately for the groups of bacterial (𝑃=0.004) and viral infections (𝑃<0.001). (c) Decline in suPAR levels separately for the groups of septic (𝑃<0.001) and nonseptic (𝑃=0.016) infected neonates. ^∗𝑃≤0.001, ^†𝑃≤0.01, compared with controls; ^§𝑃≤0.001, ^¶𝑃≤0.01, ^‖𝑃≤0.05, compared with baseline; ^⟂𝑃≤0.01, ^#𝑃≤0.05, compared with nonseptic neonates.

(a)

(b)

(c)